Clinical trial NCT03846973 - References

Tranexamic Acid — Evaluation of the Safety and Efficacy of the Second Dose of Tranexamic Acid

Citation(s)

•   Apodaca A, Olson CM Jr, Bailey J, Butler F, Eastridge BJ, Kuncir E
  Performance improvement evaluation of forward aeromedical evacuation platforms in Operation Enduring Freedom. J Trauma Acute Care Surg. 2013 Aug;75(2 Suppl 2):S157-63. doi: 10.1097/TA.0b013e318299da3e.
•   Asim M, El-Menyar A, Al-Thani H, Abdelrahman H, Zarour A, Latifi R
  Blunt traumatic injury in the Arab Middle Eastern populations. J Emerg Trauma Shock. 2014 Apr;7(2):88-96. doi: 10.4103/0974-2700.130878.
•   Ausset S, Glassberg E, Nadler R, Sunde G, Cap AP, Hoffmann C, Plang S, Sailliol A
  Tranexamic acid as part of remote damage-control resuscitation in the prehospital setting: A critical appraisal of the medical literature and available alternatives. J Trauma Acute Care Surg. 2015 Jun;78(6 Suppl 1):S70-5. doi: 10.1097/TA.0000000000000640. Review.
•   Boylan JF, Klinck JR, Sandler AN, Arellano R, Greig PD, Nierenberg H, Roger SL, Glynn MF
  Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology. 1996 Nov;85(5):1043-8; discussion 30A-31A.
•   Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet JF
  Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008 May;64(5):1211-7; discussion 1217. doi: 10.1097/TA.0b013e318169cd3c.
•   Brohi K, Singh J, Heron M, Coats T
  Acute traumatic coagulopathy. J Trauma. 2003 Jun;54(6):1127-30.
•   CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T
  The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011 Mar 26;377(9771):1096-101, 1101.e1-2. doi: 10.1016/S0140-6736(11)60278-X.
•   CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S
  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14.
•   Electronics Medicines Compendium (2011) Cyklopron Standard Product Characteristics
  http://www.medicines.org.uk/EMC/medicine/1489/SPC/Cyklokapron+Injection/ [Accessed 23rd May 2016].
•   Glassberg E, Nadler R, Gendler S, Abramovich A, Spinella PC, Gerhardt RT, Holcomb JB, Kreiss Y
  Freeze-dried plasma at the point of injury: from concept to doctrine. Shock. 2013 Dec;40(6):444-50. doi: 10.1097/SHK.0000000000000047. Review. Erratum in: Shock. 2014 Feb;41(2):172.
•   Guerriero C, Cairns J, Perel P, Shakur H, Roberts I; CRASH 2 trial collaborators
  Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One. 2011 May 3;6(5):e18987. doi: 10.1371/journal.pone.0018987.
•   Heckbert SR, Vedder NB, Hoffman W, Winn RK, Hudson LD, Jurkovich GJ, Copass MK, Harlan JM, Rice CL, Maier RV
  Outcome after hemorrhagic shock in trauma patients. J Trauma. 1998 Sep;45(3):545-9.
•   Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K
  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001886. doi: 10.1002/14651858.CD001886.pub4. Review.
•   Henry DA, Moxey AJ, Carless PA, O'Connell D, McClelland B, Henderson KM, Sly K, Laupacis A, Fergusson D
  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2001;(1):CD001886. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD001886.
•   Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, Mackway-Jones K, Parr MJ, Rizoli SB, Yukioka T, Hoyt DB, Bouillon B
  The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008 Oct;65(4):748-54. doi: 10.1097/TA.0b013e3181877a9c. Review.
•   Horrow JC, Hlavacek J, Strong MD, Collier W, Brodsky I, Goldman SM, Goel IP
  Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg. 1990 Jan;99(1):70-4.
•   Horrow JC, Van Riper DF, Strong MD, Brodsky I, Parmet JL
  Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation. 1991 Nov;84(5):2063-70.
•   Hoylaerts M, Lijnen HR, Collen D
  Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta. 1981 Feb 18;673(1):75-85.
•   Huebner BR, Dorlac WC, Cribari C
  Tranexamic Acid Use in Prehospital Uncontrolled Hemorrhage. Wilderness Environ Med. 2017 Jun;28(2S):S50-S60. doi: 10.1016/j.wem.2016.12.006. Review.
•   Inaba K
  Antifibrinolytics in trauma patients: does it MATTER? Arch Surg. 2012 Feb;147(2):119. doi: 10.1001/archsurg.2011.286. Epub 2011 Oct 17.
•   Lawson JH, Murphy MP
  Challenges for providing effective hemostasis in surgery and trauma. Semin Hematol. 2004 Jan;41(1 Suppl 1):55-64. Review.
•   Levy JH
  Antifibrinolytic therapy: new data and new concepts. Lancet. 2010 Jul 3;376(9734):3-4. doi: 10.1016/S0140-6736(10)60939-7. Epub 2010 Jun 14.
•   Lipsky AM, Abramovich A, Nadler R, Feinstein U, Shaked G, Kreiss Y, Glassberg E
  Tranexamic acid in the prehospital setting: Israel Defense Forces' initial experience. Injury. 2014 Jan;45(1):66-70. doi: 10.1016/j.injury.2013.08.025. Epub 2013 Sep 7.
•   Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ
  Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2012 Feb;147(2):113-9. doi: 10.1001/archsurg.2011.287. Epub 2011 Oct 17.
•   Neeki MM, Dong F, Toy J, Vaezazizi R, Powell J, Jabourian N, Jabourian A, Wong D, Vara R, Seiler K, Pennington TW, Powell J, Yoshida-McMath C, Kissel S, Schulz-Costello K, Mistry J, Surrusco MS, O'Bosky KR, Van Stralen D, Ludi D, Sporer K, Benson P, Kwong E, Pitts R, Culhane JT, Borger R
  Efficacy and Safety of Tranexamic Acid in Prehospital Traumatic Hemorrhagic Shock: Outcomes of the Cal-PAT Study. West J Emerg Med. 2017 Jun;18(4):673-683. doi: 10.5811/westjem.2017.2.32044. Epub 2017 Apr 19.
•   Paudyal P, Smith J, Robinson M, South A, Higginson I, Reuben A, Shaffee J, Black S, Logan S
  Tranexamic acid in major trauma: implementation and evaluation across South West England. Eur J Emerg Med. 2017 Feb;24(1):44-48.
•   Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study) (PATCH)
  Ongoing Clinical Trials. Retrieved from https://clinicaltrials.gov/ct2/show/NCT02187120 accessed on May 20, 2016
•   Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT
  Epidemiology of trauma deaths: a reassessment. J Trauma. 1995 Feb;38(2):185-93.
•   Vu EN, Schlamp RS, Wand RT, Kleine-Deters GA, Vu MP, Tallon JM
  Prehospital use of tranexamic acid for hemorrhagic shock in primary and secondary air medical evacuation. Air Med J. 2013 Sep-Oct;32(5):289-92. doi: 10.1016/j.amj.2013.05.001.
•   Wafaisade A, Lefering R, Bouillon B, Böhmer AB, Gäßler M, Ruppert M; TraumaRegister DGU
  Prehospital administration of tranexamic acid in trauma patients. Crit Care. 2016 May 12;20(1):143. doi: 10.1186/s13054-016-1322-5.
•   World Health Organisation (2011) Model Lists of Essential Medicines
  17th Ed. http://www.who.int/medicines/publications/essentialmedicines/en/ Accessed 23rd May 2016].
•   World Health Organization
  Violence, Injuries, and Disability: Biennial 2008-2009 Report. Geneva, Switzerland: WHO; 2010.
•   Zufferey PJ, Miquet M, Quenet S, Martin P, Adam P, Albaladejo P, Mismetti P, Molliex S; tranexamic acid in hip-fracture surgery (THIF) study
  Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth. 2010 Jan;104(1):23-30. doi: 10.1093/bja/aep314.

Evaluation of the Safety and Efficacy of the Second Dose of Tranexamic Acid Administration of Trauma Patients: A Randomized, Double-blind Controlled Clinical Trial

Details for clinical trial NCT03846973